Immunovant Inc. (IMVT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Immunovant Inc.

NASDAQ: IMVT · Real-Time Price · USD
16.90
0.17 (1.02%)
At close: Oct 03, 2025, 3:59 PM
17.00
0.59%
After-hours: Oct 03, 2025, 07:50 PM EDT

Immunovant Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
713.97M 635.37M 376.53M 493.82M 400.15M
Short-Term Investments
n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
7.62M n/a n/a n/a n/a
Receivables
2.51M 5.5M 885K 12.86M 1.14M
Inventory
n/a n/a n/a n/a n/a
Other Current Assets
51.18M 24.9M n/a n/a n/a
Total Current Assets
767.66M 665.77M 404.33M 512.93M 409.01M
Property-Plant & Equipment
942K 595K 1.5M 2.63M 3.48M
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
8.56M 595K 1.5M 2.63M 3.48M
Total Assets
776.22M 666.37M 405.84M 515.56M 412.49M
Account Payables
17.66M 7.16M 1.35M 18.63M 2.43M
Deferred Revenue
n/a n/a n/a n/a n/a
Short-Term Debt
98K n/a n/a n/a 1.18M
Other Current Liabilities
15.62M 14.74M 350K 171K 10.84M
Total Current Liabilities
68.78M 48.61M 43.3M 44.52M 18.77M
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a -347K n/a n/a n/a
Total Long-Term Liabilities
1.1M 347K 47K 1.22M 2.24M
Total Liabilities
68.78M 48.61M 43.34M 45.74M 21.01M
Total Debt
98K 138K 1.22M 2.36M 3.42M
Book Value
707.45M 617.76M 362.49M 469.82M 391.48M
Book Value Per Share
4.67 4.47 2.95 4.28 4.46
Common Stock
16K 14K 13K 12K 10K
Retained Earnings
-1.24B -825.68M -566.35M -355.39M -198.66M
Comprehensive Income
1.46M 1.91M 852K 404K -298K
Shareholders Equity
707.45M 617.76M 362.49M 469.82M 391.48M
Total Investments
n/a n/a n/a n/a n/a